Inogen, Inc. (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, ...
Zacks Investment Research on MSN
Inogen (INGN) up 6.8% since last earnings report: Can it continue?
A month has gone by since the last earnings report for Inogen (INGN). Shares have added about 6.8% in that time frame, outperforming the S&P 500. But investors have to be wondering, will the recent ...
Mr. Richardson joins Inogen from Baxter International Inc., where he most recently served as Chief Financial Officer and Vice ...
Inogen appointed Jason Richardson as its next chief financial officer, effective April 6, succeeding Michael Bourque. Bourque is stepping down as CFO and will work in an advisory capacity through June ...
Inogen (NASDAQ:INGN) executives highlighted improving profitability, international momentum, and a broadened product ...
GOLETA, Calif.--(BUSINESS WIRE)-- Inogen, Inc. (INGN) (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced preliminary ...
Inogen, Inc. INGN is well-poised for growth in the coming quarters due to high prospects in the portable oxygen concentrator (POC) space. The optimism, led by solid third-quarter 2025 performance and ...
Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results for the fourth quarter and the ...
Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that Kevin Smith, President and Chief Executive ...
Inogen, Inc. is a global medical technology company offering innovative respiratory products for use in the homecare setting. It supports patient respiratory care by developing, manufacturing, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results